News from askbio A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 19, 2019, 09:09 ET AskBio Receives "Best Venture Funding" Award from Southeast BIO

Asklepios BioPharmaceutical, Inc. (AskBio), a fully integrated Adeno-Associated Virus (AAV) gene therapy platform company focused on providing...


Nov 07, 2019, 17:22 ET SQZ Biotech and AskBio Announce Research Collaboration to Create Immune Tolerization Products for AAV Gene Therapies

SQZ Biotechnologies (SQZ), and Asklepios BioPharmaceutical, Inc. (AskBio), announced a research collaboration to create tolerizing antigen carriers...


Oct 24, 2019, 09:11 ET Sheila Mikhail, AskBio CEO and Cofounder, Named Springboard Enterprises' 2019 Northstar Honoree

Springboard Enterprises has named Sheila Mikhail, JD, MBA, CEO and cofounder of Asklepios BioPharmaceutical, Inc. (AskBio), as its 2019 Northstar...


Sep 17, 2019, 09:00 ET AskBio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics

Asklepios BioPharmaceutical, Inc. (AskBio), a fully integrated Adeno-Associated Virus (AAV) gene therapy platform company focused on providing...


Aug 27, 2019, 06:00 ET Viralgen Receives cGMP Certification from European Medicines Agency

Viralgen and AskBio announced that Viralgen has received Current Good Manufacturing Practices (cGMP) compliance accreditation and Pharmaceutical...


Aug 22, 2019, 12:14 ET AskBio Applauds Pfizer's Continuing Investments in Gene Therapy

In 1978, when a doctoral student named Jude Samulski started a journey of discovery for how the adeno-associated virus (AAV) could be used to safely...


Aug 13, 2019, 04:26 ET AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio

AskBio, the world's foremost clinical stage and gene therapy platform company, has acquired Synpromics, the leader in gene control synthetic promoter ...